Commit Biologics (“Commit”), a biotechnology company pioneering complement system activation and backed by €21.5 million in seed financing from Novo Holdings, Bioqube Ventures, and Korys, today ...
FAYETTEVILLE, GA, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Spinal cord injury often triggers a cascade of ...
Investor's Business Daily on MSN
Dianthus Therapeutics has appreciated 12-fold over two years. What's going on?
Dianthus Therapeutics stock shot higher Monday after the company said it would advance its experimental CIDP treatment.
The Vikasit Bharat vision -- a developed, self-reliant, globally respected India by 2047 -- is, at its core, a civilisational project. And analysts across economics, sociology, and public policy are ...
Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated macrophage/microglial activation — two key drivers of neuroinflammationMB0109 demonstrated ...
Johnson passed Kersey’s directive to his team, which trailed by three points during the approximately 10-minute and largely ...
The revived proposal calls for converting the massive, city-owned structure into a space for youth sports, technology ...
Bella Thorne looks resplendent in a red, racy, backless dress after Valentine’s Day celebrations. The 28-year-old shared a detailed carousel showcasing her risqué outfit in various poses.
New Tour Delivers a Larger-than-life Immersive Experience Proving Cascade Platinum Plus Delivers the Cleanest Dishes CINCINNATI--(BUSINESS WIRE)-- This weekend, Cascade ®, America’s #1 recommended ...
The Investigational New Drug (IND) application from Complement Therapeutics for CTx001 was previously approved by the FDA in October 2025. The US Food and Drug Administration (FDA) has granted Fast ...
FDA Fast Track designation has been granted to CTx001 for Geographic Atrophy secondary to Age-related Macular Degeneration CTx001 is an investigational AAV-based gene therapy designed to modulate ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果